COVID-19
The United States’ reckoning with racism during the COVID-19 pandemic: What can we learn and do as allergist-immunologists?

https://doi.org/10.1016/j.jaci.2020.10.034Get rights and content

Key words

COVID-19
pandemic
disparities
asthma
racism
structural racism

Cited by (0)

This study was conducted with support from the BWH H. Richard Nesson Fellowship (grant nos. K24 AI 106822 and U01 AI 110397) and NHLBI L30 HL143781.

Disclosure of potential conflict of interest: L. S. Wright is US Medical Director, ImmunoDiagnostics-Clinical Affairs, ThermoFisher Scientific. W. Phipatanakul provided/received advisory/clinical trial support from Genentech/Novartis and Sanofi/Regeneron; provided advisory support to Teva and AstraZeneca; and received clinical trial support from GlaxoSmithKline, ThermoFisher, Monaghen, Alk Abello, Lincoln diagnostics, Circassia, Merck, and Kaleo. M. Louisias has no relevant conflicts of interest.

∗

Co-first authors.

View Abstract
© 2020 American Academy of Allergy, Asthma & Immunology